Karolinska Development AB (OSTO:KDEV) Days Payable : 0.00 (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Karolinska Development AB Days Payable?

Karolinska Development AB's average Accounts Payable for the three months ended in Mar. 2024 was kr1.39 Mil. Karolinska Development AB's Cost of Goods Sold for the three months ended in Mar. 2024 was kr0.00 Mil.

The historical rank and industry rank for Karolinska Development AB's Days Payable or its related term are showing as below:

OSTO:KDEV's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 148.78
* Ranked among companies with meaningful Days Payable only.

Karolinska Development AB's Days Payable stayed the same from Mar. 2023 (0.00) to Mar. 2024 (0.00). stayed the same

Karolinska Development AB Days Payable Historical Data

The historical data trend for Karolinska Development AB's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Karolinska Development AB Days Payable Chart

Karolinska Development AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

Karolinska Development AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Payable	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Karolinska Development AB's Days Payable

For the Biotechnology subindustry, Karolinska Development AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Karolinska Development AB's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Karolinska Development AB's Days Payable distribution charts can be found below:

* The bar in red indicates where Karolinska Development AB's Days Payable falls into.

Karolinska Development AB Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Karolinska Development AB's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0.439	+	1.323)	/	2 )	/	0	*	365
=	0.881					/	0	*	365
=	N/A

Karolinska Development AB's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

	Days Payable (Q: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (1.323	+	1.451)	/	2 )	/	0	*	365 / 4
=	1.387					/	0	*	365 / 4
=	N/A

Karolinska Development AB Days Payable Related Terms

Thank you for viewing the detailed overview of Karolinska Development AB's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Karolinska Development AB (OSTO:KDEV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Karolinska Development AB (OSTO:KDEV) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

2I9:Germany

Address

TomtebodavAgen 23 A, Solna, SWE, SE-171 65

Website

https://www.karolinskadevelopment.com

Karolinska Development AB is a life science investment company. It is focused on identifying breakthrough medical innovations in the Nordic region. It selects commercially attractive medical innovations, develops innovations to the stage where the return on investment can be achieved and commercializes the innovations through the sale of companies or out-licensing of products. The company focused on profiles namely Aprea Therapeutics; Modus Therapeutics; BioArctic; Umecrine Cognition; and OssDsign.

Karolinska Development AB (OSTO:KDEV) Headlines

No Headlines